Literature DB >> 34989125

Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.

.   

Abstract

Entities:  

Year:  2022        PMID： 34989125      PMCID： PMC8732339          DOI： 10.1002/1878-0261.13139

Source DB:  PubMed          Journal:  Mol Oncol        ISSN： 1574-7891            Impact factor:   6.603


× No keyword cloud information.
The following error appeared in Section 3.5 in Ref. [1]. Instead of ‘Progressive disease‐L1 expression data were available for 87 patients’, the text should read ‘PD‐L1 expression data were available for 87 patients’. We apologize for this error.
  1 in total

1.  Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.

Authors:  Paul van der Leest; Birgitta Hiddinga; Anneke Miedema; Maria L Aguirre Azpurua; Naomi Rifaela; Arja Ter Elst; Wim Timens; Harry J M Groen; Léon C van Kempen; T Jeroen N Hiltermann; Ed Schuuring
Journal:  Mol Oncol       Date:  2021-09-25       Impact factor: 6.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.